Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation
Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. We studied this mo...
Saved in:
Published in | Critical care (London, England) Vol. 14; no. 2; p. R61 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
13.04.2010
National Library of Medicine - MEDLINE Abstracts BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations.
We studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process.
HLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone.
This study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation. |
---|---|
AbstractList | Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations.INTRODUCTIONDecreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations.We studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process.METHODSWe studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process.HLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone.RESULTSHLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone.This study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation.CONCLUSIONSThis study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation. Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. We studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process. HLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone. This study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation. Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. We studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process. HLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone. This study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation. Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. We studied this modification on CD14.sup.HIGH .sup.and CD14.sup.LOW .sup.monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process. HLA-DR on CD14.sup.HIGH .sup.monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14.sup.LOW .sup.cells only decreased after surgery, and to a lesser extent than on CD14.sup.HIGH .sup.monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14.sup.HIGH .sup.cells. In accordance with these ex vivo results, HLA-DR on CD14.sup.HIGH .sup.and CD14.sup.LOW .sup.monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14.sup.HIGH .sup.subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14.sup.HIGH .sup.versus CD14.sup.LOW .sup.monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone. This study reveals that HLA-DR expression is modulated differently on CD14.sup.HIGH .sup.(classical) versus CD14.sup.LOW .sup.(inflammatory) monocytes after systemic inflammation. INTRODUCTION: Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. METHODS: We studied this modification on CD14HIGH and CD14LOW monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process. RESULTS: HLA-DR on CD14HIGH monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14LOW cells only decreased after surgery, and to a lesser extent than on CD14HIGH monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14HIGH cells. In accordance with these ex vivo results, HLA-DR on CD14HIGH and CD14LOW monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14HIGH subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14HIGH versus CD14LOW monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone. CONCLUSIONS: This study reveals that HLA-DR expression is modulated differently on CD14HIGH (classical) versus CD14LOW (inflammatory) monocytes after systemic inflammation. Introduction Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory response syndrome (SIRS). So far, the analyses were mainly performed without taking into account monocytes subpopulations. Methods We studied this modification on CD14.sup.HIGH .sup.and CD14.sup.LOW .sup.monocytes of 20 SIRS patients undergoing abdominal aortic surgery (AAS), 20 patients undergoing carotid artery surgery (CAS), and 9 healthy controls, and we investigated mediators and intracellular molecules that may be involved in this process. Results HLA-DR on CD14.sup.HIGH .sup.monocytes started to decrease during surgery, after blood reperfusion, and was further reduced post-surgery. In contrast, HLA-DR expression on CD14.sup.LOW .sup.cells only decreased after surgery, and to a lesser extent than on CD14.sup.HIGH .sup.monocytes. Negative correlations were found between the reduction of HLA-DR expression and the change in cortisol levels for both subpopulations, whereas a negative correlation between interleukin-10 (IL-10) levels and HLA-DR modulation was only observed for CD14.sup.HIGH .sup.cells. In accordance with these ex vivo results, HLA-DR on CD14.sup.HIGH .sup.and CD14.sup.LOW .sup.monocytes of healthy donors was reduced following incubation with hydrocortisone, whereas IL-10 only acted on CD14.sup.HIGH .sup.subpopulation. Furthermore, flow cytometry revealed that the expression of IL-10 receptor was higher on CD14.sup.HIGH .sup.versus CD14.sup.LOW .sup.monocytes. In addition, hydrocortisone, and to a lesser extent IL-10, reversed the up-regulation of HLA-DR induced by bacterial products. Finally, membrane-associated RING-CH-1 protein (MARCH1) mRNA, a negative regulator of MHC class II, was up-regulated in monocytes of AAS patients on Day 1 post-surgery, and in those of healthy subjects exposed to hydrocortisone. Conclusions This study reveals that HLA-DR expression is modulated differently on CD14.sup.HIGH .sup.(classical) versus CD14.sup.LOW .sup.(inflammatory) monocytes after systemic inflammation. |
ArticleNumber | R61 |
Audience | Academic |
Author | Coriat, Pierre Cavaillon, Jean-Marc Kim, Oh Yoen Monsel, Antoine Adib-Conquy, Minou Bertrand, Michèle |
AuthorAffiliation | 1 Unit "Cytokines & Inflammation", Institut Pasteur, 28 rue Dr. Roux, Paris, 75015 France 2 Department of Anesthesiology and Critical Care, Université Pierre et Marie Curie - Paris 6, and Centre Hospitalier Universitaire Pitié-Salpêtrière, Assistance-Publique, Hôpitaux de Paris, 47 bd de l'Hôpital, Paris, 75013 France |
AuthorAffiliation_xml | – name: 1 Unit "Cytokines & Inflammation", Institut Pasteur, 28 rue Dr. Roux, Paris, 75015 France – name: 2 Department of Anesthesiology and Critical Care, Université Pierre et Marie Curie - Paris 6, and Centre Hospitalier Universitaire Pitié-Salpêtrière, Assistance-Publique, Hôpitaux de Paris, 47 bd de l'Hôpital, Paris, 75013 France |
Author_xml | – sequence: 1 givenname: Oh Yoen surname: Kim fullname: Kim, Oh Yoen – sequence: 2 givenname: Antoine surname: Monsel fullname: Monsel, Antoine – sequence: 3 givenname: Michèle surname: Bertrand fullname: Bertrand, Michèle – sequence: 4 givenname: Pierre surname: Coriat fullname: Coriat, Pierre – sequence: 5 givenname: Jean-Marc surname: Cavaillon fullname: Cavaillon, Jean-Marc – sequence: 6 givenname: Minou surname: Adib-Conquy fullname: Adib-Conquy, Minou |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20385017$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkl1rFDEUhoNU7If6E2RQ0Bun5juZG2Fp1QoLguitIZNJ1pSZZJvMKPvvzXbW2l0UyUU-zpM357w5p-AoxGABeIrgOUKSvzFGNqx5AE4Q4bSWjLCje-tjcJrzNYRISE4egWMMiWRldwK-XXrnbLJh9Lqvuvgz1Mmupl6PPoYquupquagvP1dlM8QQzWa0VZ7adVzvmFx1U_JhVeVNHu3gTeWD6_Uw3EYfg4dO99k-2c1n4Ov7d18ururlpw8fLxbLuuVQjDWlwuLGGcik7pBphWPMlJJESxzBLbRMtJQ2UCCKWIMk0bhz1DaMotY4bMkZeDvrrqd2sJ0p9STdq3Xyg04bFbVX-5Hgv6tV_KGwlKLoFYFmFmh9_IfAfsTEQc2ml7uvdo-neDPZPKrBZ2P7Xgcbp6wE5bD8AqT_JwkhTAiyJZ8fkNdxSqF4qBikHAvR4AK9mKGV7q0qvseSmtlKqgXGXBLOKSrU-V-oMrrtd5U2cr6c7114dt_MOxN-d00BXs6ASTHnZN0dgqDatuMfZ14fgMaPt41RUvD9If4LrLLhmg |
CitedBy_id | crossref_primary_10_1186_cc10130 crossref_primary_10_3389_fimmu_2023_1210961 crossref_primary_10_1007_s40620_022_01330_z crossref_primary_10_15360_1813_9779_2019_4_32_41 crossref_primary_10_1126_sciadv_abe3024 crossref_primary_10_1016_j_micinf_2017_12_008 crossref_primary_10_1007_s12026_012_8297_3 crossref_primary_10_1016_j_exger_2014_01_028 crossref_primary_10_1016_j_infect_2014_03_001 crossref_primary_10_1016_j_jointm_2024_01_001 crossref_primary_10_3390_ijms17081316 crossref_primary_10_3389_fcvm_2022_853967 crossref_primary_10_1097_CCM_0000000000000100 crossref_primary_10_1128_IAI_00703_19 crossref_primary_10_3390_biom10040507 crossref_primary_10_4049_jimmunol_1800735 crossref_primary_10_1016_j_tcam_2020_100408 crossref_primary_10_1097_JS9_0000000000001814 crossref_primary_10_3389_fimmu_2024_1454857 crossref_primary_10_1002_art_38860 crossref_primary_10_1002_anie_202113562 crossref_primary_10_1016_S2213_2600_21_00218_6 crossref_primary_10_1371_journal_pone_0293347 crossref_primary_10_2147_JIR_S360207 crossref_primary_10_1097_SHK_0b013e318299ebdd crossref_primary_10_1186_1471_2164_13_378 crossref_primary_10_4049_jimmunol_2400395 crossref_primary_10_1016_j_patbio_2012_03_011 crossref_primary_10_1016_j_amjsurg_2012_07_042 crossref_primary_10_1186_1471_230X_13_37 crossref_primary_10_1111_anae_14306 crossref_primary_10_1038_s41598_021_91948_z crossref_primary_10_1002_cyto_a_23098 crossref_primary_10_1002_eji_202350756 crossref_primary_10_1177_1533033818764720 crossref_primary_10_3389_fmolb_2022_1075686 crossref_primary_10_1016_j_jri_2024_104314 crossref_primary_10_15825_1995_1191_2020_2_53_62 crossref_primary_10_1016_j_intimp_2021_108037 crossref_primary_10_4049_jimmunol_1601168 crossref_primary_10_1177_0963689720966265 crossref_primary_10_1371_journal_pone_0169653 crossref_primary_10_1371_journal_pone_0203795 crossref_primary_10_1007_s11357_020_00213_0 crossref_primary_10_1177_0267659115612905 crossref_primary_10_4049_jimmunol_2001191 crossref_primary_10_1016_S1473_3099_19_30567_5 crossref_primary_10_3389_fimmu_2018_01293 crossref_primary_10_1097_SHK_0000000000001314 crossref_primary_10_3390_vaccines9060596 crossref_primary_10_1186_cc13787 crossref_primary_10_3389_fimmu_2021_785941 crossref_primary_10_3389_fimmu_2020_01716 crossref_primary_10_3390_ijms25052900 crossref_primary_10_1016_j_compbiomed_2021_104792 crossref_primary_10_3389_fimmu_2022_807539 crossref_primary_10_1007_s00277_014_2287_6 crossref_primary_10_1189_jlb_5A0516_240R crossref_primary_10_3390_antiox10091440 crossref_primary_10_1186_s40001_015_0180_y crossref_primary_10_1007_s12016_023_08965_1 crossref_primary_10_3390_biomedicines11030778 crossref_primary_10_1111_tan_12255 crossref_primary_10_1016_j_crmicr_2023_100215 crossref_primary_10_1016_j_vetimm_2017_06_007 crossref_primary_10_3389_fimmu_2016_00614 crossref_primary_10_3389_fimmu_2020_606649 crossref_primary_10_15252_emmm_201810128 crossref_primary_10_18821_1560_9529_2019_24_3_146_151 crossref_primary_10_3390_ani12162135 crossref_primary_10_1002_JLB_4A0220_114RR crossref_primary_10_1016_j_egja_2011_07_003 crossref_primary_10_1097_SHK_0000000000001266 crossref_primary_10_1007_s00109_014_1200_z crossref_primary_10_3390_jcm11092641 crossref_primary_10_1002_iid3_1240 crossref_primary_10_3389_fimmu_2022_1031216 crossref_primary_10_1002_ptr_7345 crossref_primary_10_1186_s12979_020_00191_z crossref_primary_10_1097_ACO_0b013e32834585d6 crossref_primary_10_1186_s13567_020_00840_7 crossref_primary_10_1002_ange_202113562 |
Cites_doi | 10.1016/0883-9441(91)90032-O 10.1523/JNEUROSCI.16-11-03745.1996 10.1378/chest.112.1.235 10.1016/S1074-7613(03)00174-2 10.1111/j.1365-3083.2007.02051.x 10.1016/0165-5728(95)00080-L 10.1002/eji.200737902 10.1007/s00134-008-1337-8 10.1189/jlb.0806510 10.1007/s00134-004-2429-8 10.1097/01.CCM.0000275271.77350.B6 10.1016/j.jtcvs.2005.01.008 10.1172/JCI115493 10.1002/eji.1830230902 10.1111/j.1365-2044.2009.06161.x 10.1097/01.CCM.0000150958.20209.A3 10.1164/rccm.200203-217OC 10.1016/j.cyto.2006.05.003 10.1038/sj.emboj.7601556 10.1172/JCI30555 10.1002/cyto.b.10031 10.1182/blood.V82.10.3170.3170 10.1086/345675 10.1186/cc7980 10.1080/110241599750008053 10.1097/00003246-200111000-00015 10.1097/00063110-199512000-00003 10.1186/cc5017 10.1073/pnas.0708874105 10.1172/JCI116306 10.1097/01.CCM.0000233875.93866.88 10.4049/jimmunol.162.4.2358 10.1016/1043-4666(93)90034-3 10.1160/TH08-07-0421 10.1016/S1043-4666(03)00090-5 10.1007/s00134-006-0204-8 10.1182/blood.V74.7.2527.2527 10.1164/rccm.200309-1329OC 10.4049/jimmunol.168.7.3536 10.1038/nri1943 10.1016/0002-9610(91)91247-G 10.1097/00024382-200206000-00001 10.1097/00006676-200210000-00006 10.1097/00007890-199706270-00026 10.1002/bjs.1800770225 10.1007/s00134-006-0205-7 10.1510/icvts.2007.158899 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2010 BioMed Central Ltd. Copyright National Library of Medicine - MEDLINE Abstracts 2010 Copyright ©2010 Kim et al.; licensee BioMed Central Ltd. 2010 Kim et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2010 BioMed Central Ltd. – notice: Copyright National Library of Medicine - MEDLINE Abstracts 2010 – notice: Copyright ©2010 Kim et al.; licensee BioMed Central Ltd. 2010 Kim et al.; licensee BioMed Central Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 7QL 7T5 C1K H94 5PM |
DOI | 10.1186/cc8959 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Bacteriology Abstracts (Microbiology B) Immunology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Bacteriology Abstracts (Microbiology B) Environmental Sciences and Pollution Management |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1364-8535 1466-609X |
EndPage | R61 |
ExternalDocumentID | PMC2887183 oai_biomedcentral_com_cc8959 2062585291 A226836641 20385017 10_1186_cc8959 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | France |
GeographicLocations_xml | – name: France |
GroupedDBID | --- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF AAFWJ AAJSJ AASML AAWTL AAYXX ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFPKN AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CITATION CS3 DIK E3Z EBLON EBS EJD F5P GROUPED_DOAJ GX1 H13 HYE IAO IHR INH INR ITC KQ8 O5R O5S OK1 PIMPY PQQKQ RBZ ROL RPM RSV SJN SMD SOJ TR2 U2A WOQ YOC 7X7 88E 8FI 8FJ ABUWG AFKRA BPHCQ BVXVI C1A CCPQU CGR CUY CVF EBD ECM EIF EMOBN FYUFA HMCUK M1P NPM PHGZT PROAC PSQYO SV3 UKHRP K9. 7X8 7QL 7T5 C1K H94 -5E -5G -BR 3V. ABVAZ ACRMQ ADINQ AFGXO AFNRJ C24 5PM |
ID | FETCH-LOGICAL-b607t-447e29fc058ad1cb7f55ccc87b3f32b0e57b4490714159183a2df4e9541bcf2e3 |
IEDL.DBID | RBZ |
ISSN | 1364-8535 1466-609X |
IngestDate | Thu Aug 21 18:06:27 EDT 2025 Wed May 22 07:12:12 EDT 2024 Fri Jul 11 09:58:18 EDT 2025 Fri Jul 11 12:13:13 EDT 2025 Sun Jun 29 16:11:32 EDT 2025 Tue Jun 17 20:36:03 EDT 2025 Tue Jun 10 20:29:47 EDT 2025 Thu Apr 03 07:04:57 EDT 2025 Thu Apr 24 22:58:34 EDT 2025 Tue Jul 01 04:22:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b607t-447e29fc058ad1cb7f55ccc87b3f32b0e57b4490714159183a2df4e9541bcf2e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | http://dx.doi.org/10.1186/cc8959 |
PMID | 20385017 |
PQID | 504627792 |
PQPubID | 44363 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_2887183 biomedcentral_primary_oai_biomedcentral_com_cc8959 proquest_miscellaneous_746085304 proquest_miscellaneous_733357734 proquest_journals_504627792 gale_infotracmisc_A226836641 gale_infotracacademiconefile_A226836641 pubmed_primary_20385017 crossref_primary_10_1186_cc8959 crossref_citationtrail_10_1186_cc8959 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-04-13 |
PublicationDateYYYYMMDD | 2010-04-13 |
PublicationDate_xml | – month: 04 year: 2010 text: 2010-04-13 day: 13 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Critical care (London, England) |
PublicationTitleAlternate | Crit Care |
PublicationYear | 2010 |
Publisher | BioMed Central Ltd National Library of Medicine - MEDLINE Abstracts BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: National Library of Medicine - MEDLINE Abstracts – name: BioMed Central |
References | M Frankenberger (8389_CR41) 1995; 45 K Asehnoune (8389_CR50) 2006; 34 A Pachot (8389_CR53) 2005; 33 RC Bone (8389_CR1) 1997; 112 JW Haveman (8389_CR12) 2006; 10 G Monneret (8389_CR9) 2006; 32 P Gessler (8389_CR42) 2005; 130 T Volk (8389_CR36) 2003; 24 A Cabié (8389_CR33) 1993; 5 Y Matsuki (8389_CR24) 2007; 26 A Richter (8389_CR11) 1999; 165 J Thibodeau (8389_CR23) 2008; 38 B Passlick (8389_CR26) 1989; 74 JC Strohmeyer (8389_CR19) 2003; 53 JM Handy (8389_CR43) 2010; 65 JMMvan den Berk (8389_CR15) 1997; 63 K Asadullah (8389_CR45) 1995; 2 HW Ziegler-Heitbrock (8389_CR27) 1993; 23 T Fumeaux (8389_CR20) 2006; 32 H Ziegler-Heitbrock (8389_CR35) 1995; 45 CE McCall (8389_CR5) 1993; 91 WG Cheadle (8389_CR14) 1991; 161 G Fingerle (8389_CR29) 1993; 82 OY Kim (8389_CR34) 2009; 13 IJ Elenkov (8389_CR47) 1995; 61 L Ziegler-Heitbrock (8389_CR39) 2007; 81 A Satoh (8389_CR17) 2002; 25 T Fumeaux (8389_CR22) 2002; 166 KU Belge (8389_CR40) 2002; 168 Y Le Tulzo (8389_CR21) 2004; 169 T Fumeaux (8389_CR44) 2004; 30 T Volk (8389_CR46) 2001; 29 KJ Tracey (8389_CR51) 2007; 117 F Geissmann (8389_CR28) 2003; 19 A De Gassart (8389_CR25) 2008; 105 SG Muehlstedt (8389_CR16) 2002; 17 A Franke (8389_CR13) 2008; 7 P Maturana (8389_CR6) 1991; 6 J Skrzeczynska-Moncznik (8389_CR30) 2008; 67 S Weijer (8389_CR52) 2002; 186 GF Zhu (8389_CR48) 1996; 16 F Venet (8389_CR3) 2009; 35 AF Petit-Bertron (8389_CR31) 2005; 29 E Ates (8389_CR37) 2004; 67 JM Cavaillon (8389_CR38) 1992; 38 RS Hotchkiss (8389_CR7) 2006; 6 M Adib-Conquy (8389_CR32) 2006; 34 F Venet (8389_CR18) 2007; 35 A Lekkou (8389_CR10) 2004; 11 M Adib-Conquy (8389_CR2) 2009; 101 M Delgado (8389_CR49) 1999; 162 MJ Hershman (8389_CR8) 1990; 77 C Muñoz (8389_CR4) 1991; 88 18389477 - Eur J Immunol. 2008 May;38(5):1225-30 8642417 - J Neurosci. 1996 Jun 1;16(11):3745-52 11907116 - J Immunol. 2002 Apr 1;168(7):3536-42 18305173 - Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3491-6 7693040 - Blood. 1993 Nov 15;82(10):3170-6 2478233 - Blood. 1989 Nov 15;74(7):2527-34 1862821 - Am J Surg. 1991 Jun;161(6):639-45 19132187 - Thromb Haemost. 2009 Jan;101(1):36-47 16850005 - Crit Care Med. 2006 Sep;34(9):2377-85 12406851 - Am J Respir Crit Care Med. 2002 Dec 1;166(11):1475-82 2317682 - Br J Surg. 1990 Feb;77(2):204-7 15368036 - Intensive Care Med. 2004 Nov;30(11):2028-37 14609565 - Cytokine. 2003 Dec 21;24(6):237-43 18055481 - Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):207-11 14715564 - Clin Diagn Lab Immunol. 2004 Jan;11(1):161-7 17255932 - EMBO J. 2007 Feb 7;26(3):846-54 7690321 - Eur J Immunol. 1993 Sep;23(9):2053-8 15587331 - Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):250-4 12069178 - Shock. 2002 Jun;17(6):443-50 9228382 - Chest. 1997 Jul;112(1):235-43 17568330 - Crit Care Med. 2007 Aug;35(8):1910-7 7583350 - J Inflamm. 1995;45(1):13-26 12370535 - Pancreas. 2002 Oct;25(3):245-50 1423923 - Circ Shock. 1992 Oct;38(2):145-52 7593548 - J Neuroimmunol. 1995 Sep;61(2):123-31 12447760 - J Infect Dis. 2002 Dec 15;186(12):1748-53 16899122 - Crit Care. 2006;10(4):R119 11700410 - Crit Care Med. 2001 Nov;29(11):2137-42 9422205 - Eur J Emerg Med. 1995 Dec;2(4):184-90 15579372 - Cytokine. 2005 Jan 7;29(1):1-12 19638210 - Crit Care. 2009;13(4):R124 16741700 - Intensive Care Med. 2006 Aug;32(8):1175-83 12717692 - Cytometry B Clin Cytom. 2003 May;53(1):54-62 15644645 - Crit Care Med. 2005 Jan;33(1):31-8; discussion 236-7 15028560 - Am J Respir Crit Care Med. 2004 May 15;169(10):1144-51 18201370 - Scand J Immunol. 2008 Feb;67(2):152-9 9973516 - J Immunol. 1999 Feb 15;162(4):2358-67 9210517 - Transplantation. 1997 Jun 27;63(12):1846-8 16790355 - Cytokine. 2006 May;34(3-4):212-8 17273548 - J Clin Invest. 2007 Feb;117(2):289-96 18946659 - Intensive Care Med. 2009 Apr;35(4):678-86 17039247 - Nat Rev Immunol. 2006 Nov;6(11):813-22 15999041 - J Thorac Cardiovasc Surg. 2005 Jul;130(1):54-60 12871640 - Immunity. 2003 Jul;19(1):71-82 17135573 - J Leukoc Biol. 2007 Mar;81(3):584-92 1939659 - J Clin Invest. 1991 Nov;88(5):1747-54 19889110 - Anaesthesia. 2010 Jan;65(1):27-35 7583353 - J Inflamm. 1995;45(1):56-63 16741699 - Intensive Care Med. 2006 Aug;32(8):1106-8 10574102 - Eur J Surg. 1999 Oct;165(10):947-51 7680670 - J Clin Invest. 1993 Mar;91(3):853-61 8142599 - Cytokine. 1993 Sep;5(5):448-53 |
References_xml | – volume: 6 start-page: 42 year: 1991 ident: 8389_CR6 publication-title: J Crit Care doi: 10.1016/0883-9441(91)90032-O – volume: 16 start-page: 3745 year: 1996 ident: 8389_CR48 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.16-11-03745.1996 – volume: 112 start-page: 235 year: 1997 ident: 8389_CR1 publication-title: Chest doi: 10.1378/chest.112.1.235 – volume: 19 start-page: 71 year: 2003 ident: 8389_CR28 publication-title: Immunity doi: 10.1016/S1074-7613(03)00174-2 – volume: 11 start-page: 161 year: 2004 ident: 8389_CR10 publication-title: Clin Diagn Lab Immunol – volume: 67 start-page: 152 year: 2008 ident: 8389_CR30 publication-title: Scand J Immunol doi: 10.1111/j.1365-3083.2007.02051.x – volume: 61 start-page: 123 year: 1995 ident: 8389_CR47 publication-title: J Neuroimmunol doi: 10.1016/0165-5728(95)00080-L – volume: 38 start-page: 1225 year: 2008 ident: 8389_CR23 publication-title: Eur J Immunol doi: 10.1002/eji.200737902 – volume: 35 start-page: 678 year: 2009 ident: 8389_CR3 publication-title: Intensive Care Med doi: 10.1007/s00134-008-1337-8 – volume: 81 start-page: 584 year: 2007 ident: 8389_CR39 publication-title: J Leukoc Biol doi: 10.1189/jlb.0806510 – volume: 30 start-page: 2028 year: 2004 ident: 8389_CR44 publication-title: Intensive Care Medicine doi: 10.1007/s00134-004-2429-8 – volume: 35 start-page: 1910 year: 2007 ident: 8389_CR18 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000275271.77350.B6 – volume: 130 start-page: 54 year: 2005 ident: 8389_CR42 publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2005.01.008 – volume: 88 start-page: 1747 year: 1991 ident: 8389_CR4 publication-title: J Clin Invest doi: 10.1172/JCI115493 – volume: 23 start-page: 2053 year: 1993 ident: 8389_CR27 publication-title: Eur J Immunol doi: 10.1002/eji.1830230902 – volume: 45 start-page: 13 year: 1995 ident: 8389_CR35 publication-title: J Inflamm – volume: 65 start-page: 27 year: 2010 ident: 8389_CR43 publication-title: Anaesthesia doi: 10.1111/j.1365-2044.2009.06161.x – volume: 33 start-page: 31 year: 2005 ident: 8389_CR53 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000150958.20209.A3 – volume: 166 start-page: 1475 year: 2002 ident: 8389_CR22 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200203-217OC – volume: 34 start-page: 212 year: 2006 ident: 8389_CR50 publication-title: Cytokine doi: 10.1016/j.cyto.2006.05.003 – volume: 26 start-page: 846 year: 2007 ident: 8389_CR24 publication-title: Embo J doi: 10.1038/sj.emboj.7601556 – volume: 117 start-page: 289 year: 2007 ident: 8389_CR51 publication-title: J Clin Invest doi: 10.1172/JCI30555 – volume: 53 start-page: 54 year: 2003 ident: 8389_CR19 publication-title: Cytometry B Clin Cytom doi: 10.1002/cyto.b.10031 – volume: 82 start-page: 3170 year: 1993 ident: 8389_CR29 publication-title: Blood doi: 10.1182/blood.V82.10.3170.3170 – volume: 186 start-page: 1748 year: 2002 ident: 8389_CR52 publication-title: J Infect Dis doi: 10.1086/345675 – volume: 13 start-page: R124 year: 2009 ident: 8389_CR34 publication-title: Crit Care doi: 10.1186/cc7980 – volume: 165 start-page: 947 year: 1999 ident: 8389_CR11 publication-title: Eur J Surg doi: 10.1080/110241599750008053 – volume: 67 start-page: 250 year: 2004 ident: 8389_CR37 publication-title: Acta Gastroenterol Belg – volume: 45 start-page: 56 year: 1995 ident: 8389_CR41 publication-title: Journal of Inflammation – volume: 29 start-page: 2137 year: 2001 ident: 8389_CR46 publication-title: Crit Care Med doi: 10.1097/00003246-200111000-00015 – volume: 2 start-page: 184 year: 1995 ident: 8389_CR45 publication-title: Eur J Emerg Med doi: 10.1097/00063110-199512000-00003 – volume: 10 start-page: R119 year: 2006 ident: 8389_CR12 publication-title: Crit Care doi: 10.1186/cc5017 – volume: 105 start-page: 3491 year: 2008 ident: 8389_CR25 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0708874105 – volume: 38 start-page: 145 year: 1992 ident: 8389_CR38 publication-title: Circ Shock – volume: 91 start-page: 853 year: 1993 ident: 8389_CR5 publication-title: J Clin Invest doi: 10.1172/JCI116306 – volume: 34 start-page: 2377 year: 2006 ident: 8389_CR32 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000233875.93866.88 – volume: 162 start-page: 2358 year: 1999 ident: 8389_CR49 publication-title: J Immunol doi: 10.4049/jimmunol.162.4.2358 – volume: 5 start-page: 448 year: 1993 ident: 8389_CR33 publication-title: Cytokine doi: 10.1016/1043-4666(93)90034-3 – volume: 101 start-page: 36 year: 2009 ident: 8389_CR2 publication-title: Thromb Haemost doi: 10.1160/TH08-07-0421 – volume: 24 start-page: 237 year: 2003 ident: 8389_CR36 publication-title: Cytokine doi: 10.1016/S1043-4666(03)00090-5 – volume: 32 start-page: 1175 year: 2006 ident: 8389_CR9 publication-title: Intensive Care Med doi: 10.1007/s00134-006-0204-8 – volume: 74 start-page: 2527 year: 1989 ident: 8389_CR26 publication-title: Blood doi: 10.1182/blood.V74.7.2527.2527 – volume: 169 start-page: 1144 year: 2004 ident: 8389_CR21 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200309-1329OC – volume: 168 start-page: 3536 year: 2002 ident: 8389_CR40 publication-title: J Immunol doi: 10.4049/jimmunol.168.7.3536 – volume: 6 start-page: 813 year: 2006 ident: 8389_CR7 publication-title: Nat Rev Immunol doi: 10.1038/nri1943 – volume: 29 start-page: 1 year: 2005 ident: 8389_CR31 publication-title: Cytokine – volume: 161 start-page: 639 year: 1991 ident: 8389_CR14 publication-title: Am J Surg doi: 10.1016/0002-9610(91)91247-G – volume: 17 start-page: 443 year: 2002 ident: 8389_CR16 publication-title: Shock doi: 10.1097/00024382-200206000-00001 – volume: 25 start-page: 245 year: 2002 ident: 8389_CR17 publication-title: Pancreas doi: 10.1097/00006676-200210000-00006 – volume: 63 start-page: 1846 year: 1997 ident: 8389_CR15 publication-title: Transplantation doi: 10.1097/00007890-199706270-00026 – volume: 77 start-page: 204 year: 1990 ident: 8389_CR8 publication-title: Br J Surg doi: 10.1002/bjs.1800770225 – volume: 32 start-page: 1106 year: 2006 ident: 8389_CR20 publication-title: Intensive Care Med doi: 10.1007/s00134-006-0205-7 – volume: 7 start-page: 207 year: 2008 ident: 8389_CR13 publication-title: Interact Cardiovasc Thorac Surg doi: 10.1510/icvts.2007.158899 – reference: 17273548 - J Clin Invest. 2007 Feb;117(2):289-96 – reference: 12406851 - Am J Respir Crit Care Med. 2002 Dec 1;166(11):1475-82 – reference: 12069178 - Shock. 2002 Jun;17(6):443-50 – reference: 7693040 - Blood. 1993 Nov 15;82(10):3170-6 – reference: 7583350 - J Inflamm. 1995;45(1):13-26 – reference: 12871640 - Immunity. 2003 Jul;19(1):71-82 – reference: 18389477 - Eur J Immunol. 2008 May;38(5):1225-30 – reference: 17255932 - EMBO J. 2007 Feb 7;26(3):846-54 – reference: 19889110 - Anaesthesia. 2010 Jan;65(1):27-35 – reference: 12447760 - J Infect Dis. 2002 Dec 15;186(12):1748-53 – reference: 16790355 - Cytokine. 2006 May;34(3-4):212-8 – reference: 17568330 - Crit Care Med. 2007 Aug;35(8):1910-7 – reference: 16741700 - Intensive Care Med. 2006 Aug;32(8):1175-83 – reference: 17039247 - Nat Rev Immunol. 2006 Nov;6(11):813-22 – reference: 9422205 - Eur J Emerg Med. 1995 Dec;2(4):184-90 – reference: 16850005 - Crit Care Med. 2006 Sep;34(9):2377-85 – reference: 16741699 - Intensive Care Med. 2006 Aug;32(8):1106-8 – reference: 15644645 - Crit Care Med. 2005 Jan;33(1):31-8; discussion 236-7 – reference: 7680670 - J Clin Invest. 1993 Mar;91(3):853-61 – reference: 7593548 - J Neuroimmunol. 1995 Sep;61(2):123-31 – reference: 10574102 - Eur J Surg. 1999 Oct;165(10):947-51 – reference: 18201370 - Scand J Immunol. 2008 Feb;67(2):152-9 – reference: 15028560 - Am J Respir Crit Care Med. 2004 May 15;169(10):1144-51 – reference: 8642417 - J Neurosci. 1996 Jun 1;16(11):3745-52 – reference: 18305173 - Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3491-6 – reference: 19132187 - Thromb Haemost. 2009 Jan;101(1):36-47 – reference: 8142599 - Cytokine. 1993 Sep;5(5):448-53 – reference: 15368036 - Intensive Care Med. 2004 Nov;30(11):2028-37 – reference: 15579372 - Cytokine. 2005 Jan 7;29(1):1-12 – reference: 9210517 - Transplantation. 1997 Jun 27;63(12):1846-8 – reference: 15587331 - Acta Gastroenterol Belg. 2004 Jul-Sep;67(3):250-4 – reference: 2478233 - Blood. 1989 Nov 15;74(7):2527-34 – reference: 1862821 - Am J Surg. 1991 Jun;161(6):639-45 – reference: 2317682 - Br J Surg. 1990 Feb;77(2):204-7 – reference: 9228382 - Chest. 1997 Jul;112(1):235-43 – reference: 15999041 - J Thorac Cardiovasc Surg. 2005 Jul;130(1):54-60 – reference: 1423923 - Circ Shock. 1992 Oct;38(2):145-52 – reference: 1939659 - J Clin Invest. 1991 Nov;88(5):1747-54 – reference: 12370535 - Pancreas. 2002 Oct;25(3):245-50 – reference: 16899122 - Crit Care. 2006;10(4):R119 – reference: 9973516 - J Immunol. 1999 Feb 15;162(4):2358-67 – reference: 7583353 - J Inflamm. 1995;45(1):56-63 – reference: 11907116 - J Immunol. 2002 Apr 1;168(7):3536-42 – reference: 14715564 - Clin Diagn Lab Immunol. 2004 Jan;11(1):161-7 – reference: 17135573 - J Leukoc Biol. 2007 Mar;81(3):584-92 – reference: 7690321 - Eur J Immunol. 1993 Sep;23(9):2053-8 – reference: 18946659 - Intensive Care Med. 2009 Apr;35(4):678-86 – reference: 14609565 - Cytokine. 2003 Dec 21;24(6):237-43 – reference: 18055481 - Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):207-11 – reference: 11700410 - Crit Care Med. 2001 Nov;29(11):2137-42 – reference: 12717692 - Cytometry B Clin Cytom. 2003 May;53(1):54-62 – reference: 19638210 - Crit Care. 2009;13(4):R124 |
SSID | ssj0017863 |
Score | 2.2863016 |
Snippet | Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic inflammatory... Introduction Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic... INTRODUCTION: Decreased expression of human leukocyte antigen class II (HLA-DR) on monocytes is a hallmark of altered immune status in patients with a systemic... |
SourceID | pubmedcentral biomedcentral proquest gale pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | R61 |
SubjectTerms | Aged Aorta, Abdominal - immunology Aorta, Abdominal - surgery Carotid Arteries - immunology Carotid Arteries - surgery Case-Control Studies Development and progression Down-Regulation - immunology Female Flow Cytometry Gene expression Gene Expression - immunology Genetic aspects Genetic regulation HLA class II antigens HLA-DR Antigens - biosynthesis HLA-DR Antigens - immunology Humans Inflammation Lipopolysaccharide Receptors - metabolism Male Middle Aged Monocytes Monocytes - cytology Monocytes - immunology Monocytes - metabolism Observations Physiological aspects Polymerase Chain Reaction - methods Properties Systemic Inflammatory Response Syndrome - immunology Systemic Inflammatory Response Syndrome - metabolism |
Title | Differential down-regulation of HLA-DR on monocyte subpopulations during systemic inflammation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/20385017 https://www.proquest.com/docview/504627792 https://www.proquest.com/docview/733357734 https://www.proquest.com/docview/746085304 http://dx.doi.org/10.1186/cc8959 https://pubmed.ncbi.nlm.nih.gov/PMC2887183 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIiEuqLzTluIDiJNF4mdyXCjVClEOiEoVB6zYsdVKq2zV3T3w7xnH2VCv4MIx8jhKvpnJzGQ8MwBv6lK4LsiSatt5KgRzFMOglqIpdgENhuVDi43zr2p-IT5fyss9IH_P4Fe1eu9c3cjmHtxnAq1fjMc__JjyBLoeZqVVXAmKhkeO04P-7NupY19k5mf3I3zHCuUnJO-YnLMDeDT6imSWmPsY9nz_BB6cj9nwp_DzdJxuglq6IB3G0_Q2jZZHsMkykPmXGT39RvAChW3pfq09WW3szTSza0VSlSJJ_ZyvHUF5QxFJ5YzP4OLs0_ePczrOS6BWlXqNSGvPmuBKWbdd5awOUjqEQVseOLOll9oK0cSSJXRiUJdb1gXhGykq6wLz_Dns98vevwSigvMKQz9bDgEcht-trx1TXcuVDVwUwDJYzU3qjWFit-p8BRXHJF4U8HaLvXFjB_I4CGNhhkikVhPd64lue99dineRdSYqId7BtWMtAT58bGdlZuhU1lwpURVwnFGi8rhs-WjLfDMq78rIWLCrdcMKINNq3BjPo_V-uVkZzTmXWkcg_kkiFLqzvESSF0mYppdhMR2LwluAzsQsQzFf6a-vht7fDI0Ccu7wf_A_gofp7IOgFT-G_fXtxr9Cl2ptT4ZfESeDbv0GfoQl0Q |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQw0IIiAZeKZ0lbqA8gTobEz-S4tFQL7PZQtVLFASt2bFFpla26uwf-vuPYm25W6oVjNGMrmYdnJp4HQh_LnNvGi5wo0zjCObUEwqCagCm2HgyGYV2LjemZHF_yn1fiKv1wC7UwNjX4D3lPXzYr0Gfdsb3OFovKXsqv1paVqB6jJ0oIFSYYnH_73d8iqLKbpFYwyQmYJZFmC92v26pynw2M0_YRvWGjhvmTGwbp9AXaTZ4kHsV3fYkeufYVejpNd-Wv0Z-TNPsEdHiGG4i2yW0cPA-swHOPx5MROTnH8ACiOLf_lg4vVuamn-i1wLGGEcduz9cWgzSCAMVixzfo8vT7xfGYpGkKxMhcLYEPytHK21yUdVNYo7wQFsigDPOMmtwJZTivQkETuDig6TVtPHeV4IWxnjr2Fu2089a9Q1h66yQEhibvwjsIzmtXWiqbmknjGc8QHZBV38TOGTr0sh5CgKk68iJDn9a01zb1Jw9jMma6i1NK2eMd9XjrfbcxPgfW6aCisIOtU6UBvHxodqVH4HKWTEpeZOhwgAmqZQfggzXzdVLthRahnFepimYI99CwMGSrtW6-WmjFGBNKBUI8iMIlOLssB5S9KEz9x9BwWQvCmyE1ELMBFYeQ9vpv1xmcgskAzu3_D_2P0LPxxXSiJz_Ofh2g5zFLgpOCHaKd5e3KvQfna2k-dBp2BzgwNAM |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUXVJ4NLdQHECfTxM_kuLCsFmgrVFGp4oAVO7aoWGVX3d1D_z3j2Bs2K3HhlsjjKJlHZkaemQ-hN2XObeNFTpRpHOGcWgJpUE3AFVsPDsOwbsTG-YWcXvEv1-I64ZyGXhibBvyHuqf32x3os-63DRf29-mi8dHaS3lqbVmJ6j56oIRQwTIvP_zojxFU2UGpFUxyAn5JJHChv_t22txnA--0-4_eclLDAsotjzQ5QI9SKIlHUfaP0T3XPkH75-mw_Cn6OU7gJ2DEM9xAuk1uI_I8yALPPZ6ejcj4EsMN6OLc3q0cXq7Noof0WuLYxIjjuOcbi0EdQYNit-MzdDX59P3jlCQ4BWJkrlYgCOVo5W0uyroprFFeCAtsUIZ5Rk3uhDKcV6GjCWIcMPWaNp67SvDCWE8de4722nnrDhGW3joJmaHJu_wOsvPalZbKpmbSeMYzRAds1Ys4OkOHYdbDFZCqjrLI0NsN77VNA8oDTsZMd4lKKXu6k55u89xdindBdDrYaNCYOrUawMuHaVd6BDFnyaTkRYaOB5RgW3awfLQRvk62vdQi9PMqVdEM4X41bAzlaq2br5daMcaEUoER_yThEqJdlgPJi6hM_cfQcFoLypshNVCzAReHK-3Nr240OAWfAZJ7-T_8P0H738YTffb54usRehirJDgp2DHaW92u3SsIvlbmdWdgfwClhTPO |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+down-regulation+of+HLA-DR+on+monocyte+subpopulations+during+systemic+inflammation&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Kim%2C+Oh+Yoen&rft.au=Monsel%2C+Antoine&rft.au=Bertrand%2C+Mich%C3%A8le&rft.au=Coriat%2C+Pierre&rft.date=2010-04-13&rft.pub=BioMed+Central+Ltd&rft.issn=1364-8535&rft.volume=14&rft.spage=R61&rft_id=info:doi/10.1186%2Fcc8959&rft.externalDocID=A226836641 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon |